| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.3 |
7e-17 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
1e-16 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
7e-16 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
2e-15 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.27 |
3e-15 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.26 |
7e-15 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
4e-14 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
6e-14 |
| mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.27 |
4e-13 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
5e-13 |